MX2014012742A - Composicion para el tratamiento de transtornos metabólicos. - Google Patents
Composicion para el tratamiento de transtornos metabólicos.Info
- Publication number
- MX2014012742A MX2014012742A MX2014012742A MX2014012742A MX2014012742A MX 2014012742 A MX2014012742 A MX 2014012742A MX 2014012742 A MX2014012742 A MX 2014012742A MX 2014012742 A MX2014012742 A MX 2014012742A MX 2014012742 A MX2014012742 A MX 2014012742A
- Authority
- MX
- Mexico
- Prior art keywords
- composition
- metabolic disorders
- relates
- extract
- treating metabolic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Reproductive Health (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Abstract
La presente invención se refiere a una composición herbal que comprende una cantidad terapéuticamnete efectiva de un extracto de la planta Terninalia elliptica como ingrediente activo y, opcionalmente, un portador farmacéuticamente aceptable. La presente invención también se refiere a un proceso para la preparación del extracto. La invención también se refiere a un método para el tratamiento de los trastornos metabólicos mediante dicha composición. La presente invención también se refiere a una composición que comprende una cantidad terapéuticamente efectiva de un extracto de la planta Terminalia elliptica para uso en combinación con uno o más agentes terapéuticos activos adicionales para el tratamiento de trastornos metabólicos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261636792P | 2012-04-23 | 2012-04-23 | |
PCT/IB2013/053155 WO2013160811A1 (en) | 2012-04-23 | 2013-04-22 | Composition for treating metabolic disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2014012742A true MX2014012742A (es) | 2015-04-08 |
Family
ID=49482298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014012742A MX2014012742A (es) | 2012-04-23 | 2013-04-22 | Composicion para el tratamiento de transtornos metabólicos. |
Country Status (16)
Country | Link |
---|---|
US (1) | US20150290265A1 (es) |
EP (1) | EP2841080A4 (es) |
JP (1) | JP2015514797A (es) |
KR (1) | KR20150003862A (es) |
CN (1) | CN104244962A (es) |
AU (1) | AU2013254329A1 (es) |
BR (1) | BR112014026326A2 (es) |
CA (1) | CA2870907A1 (es) |
IL (1) | IL235317A0 (es) |
IN (1) | IN2014MN02269A (es) |
MX (1) | MX2014012742A (es) |
NZ (1) | NZ701133A (es) |
RU (1) | RU2014145931A (es) |
SA (1) | SA113340494B1 (es) |
TW (1) | TW201343174A (es) |
WO (1) | WO2013160811A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016099944A1 (en) * | 2014-12-19 | 2016-06-23 | Halo Life Science, Llc | Use of ellagic acid dihydrate in pharmaceutical formulations to regulate blood glucose levels |
EP3529245A4 (en) | 2016-10-24 | 2020-12-23 | Yumanity Therapeutics, Inc. | COMPOUNDS AND USES OF THE LATEST |
EA201991650A1 (ru) | 2017-01-06 | 2020-01-20 | Юманити Терапьютикс, Инк. | Способы лечения неврологических расстройств |
US11873298B2 (en) | 2017-10-24 | 2024-01-16 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
MX2020007394A (es) | 2018-01-10 | 2020-09-03 | Brightseed Inc | Metodo para modular el metabolismo. |
AU2020383340A1 (en) | 2019-11-11 | 2022-06-09 | Brightseed, Inc | Extract, consumable product and method for enriching bioactive metabolite in an extract |
KR102408566B1 (ko) * | 2020-04-09 | 2022-06-16 | 대한민국 | 터미날리아 비아라타 추출물을 이용한 피부 주름 개선용 조성물 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005053864A (ja) * | 2003-08-06 | 2005-03-03 | Ryukyu Bio Resource Kaihatsu:Kk | 糖尿病疾患予防・治療剤 |
JP2006188486A (ja) * | 2004-12-07 | 2006-07-20 | Toyo Shinyaku:Kk | 体脂肪蓄積抑制または低減剤 |
WO2006090198A2 (en) * | 2005-02-23 | 2006-08-31 | Avestha Gengraine Technologies Pvt Ltd. | Plant extracts and methods and uses therefore |
-
2013
- 2013-04-22 TW TW102114264A patent/TW201343174A/zh unknown
- 2013-04-22 AU AU2013254329A patent/AU2013254329A1/en not_active Abandoned
- 2013-04-22 BR BR112014026326A patent/BR112014026326A2/pt not_active IP Right Cessation
- 2013-04-22 US US14/391,762 patent/US20150290265A1/en not_active Abandoned
- 2013-04-22 WO PCT/IB2013/053155 patent/WO2013160811A1/en active Application Filing
- 2013-04-22 JP JP2015507634A patent/JP2015514797A/ja active Pending
- 2013-04-22 IN IN2269MUN2014 patent/IN2014MN02269A/en unknown
- 2013-04-22 RU RU2014145931A patent/RU2014145931A/ru unknown
- 2013-04-22 CA CA 2870907 patent/CA2870907A1/en not_active Abandoned
- 2013-04-22 NZ NZ701133A patent/NZ701133A/en not_active IP Right Cessation
- 2013-04-22 MX MX2014012742A patent/MX2014012742A/es unknown
- 2013-04-22 EP EP13781126.1A patent/EP2841080A4/en not_active Withdrawn
- 2013-04-22 CN CN201380021515.3A patent/CN104244962A/zh active Pending
- 2013-04-22 KR KR20147032772A patent/KR20150003862A/ko not_active Application Discontinuation
- 2013-04-23 SA SA113340494A patent/SA113340494B1/ar unknown
-
2014
- 2014-10-23 IL IL235317A patent/IL235317A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
TW201343174A (zh) | 2013-11-01 |
US20150290265A1 (en) | 2015-10-15 |
AU2013254329A1 (en) | 2014-11-13 |
CA2870907A1 (en) | 2013-10-31 |
EP2841080A4 (en) | 2015-11-25 |
IL235317A0 (en) | 2014-12-31 |
WO2013160811A1 (en) | 2013-10-31 |
SA113340494B1 (ar) | 2015-12-24 |
EP2841080A1 (en) | 2015-03-04 |
BR112014026326A2 (pt) | 2017-06-27 |
JP2015514797A (ja) | 2015-05-21 |
IN2014MN02269A (es) | 2015-07-24 |
NZ701133A (en) | 2016-08-26 |
CN104244962A (zh) | 2014-12-24 |
KR20150003862A (ko) | 2015-01-09 |
RU2014145931A (ru) | 2016-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SA113340494B1 (ar) | تركيبة لعلاج اضطرابات أيضية | |
NZ702663A (en) | Nuclear transport modulators and uses thereof | |
MX2018000421A (es) | Composiciones de retinoides topicos. | |
SG10201810888XA (en) | Compositions and methods comprising bupropion or related compounds and dextromethorphan | |
WO2014205389A8 (en) | Nuclear transport modulators and uses thereof | |
NZ630805A (en) | Pharmaceutical combinations comprising a thionucleotide analog | |
NZ700881A (en) | Compositions and methods comprising celecoxib or related compounds and dextromethorphan | |
GB201111485D0 (en) | Drug composition and its use in therapy | |
EP2490700A4 (en) | EXTERNAL SKIN CARE COMPOSITION COMPRISING SALT AND SUGAR AS ACTIVE INGREDIENTS FOR PREVENTING AND TREATING VAGINOSIS AND USE THEREOF | |
WO2015056094A3 (en) | Pharmaceutical composition comprising a trpa1 antagonist and an analgesic agent | |
MD4563C1 (ro) | Produs de comicronizare cu conţinut de acetat de ulipristal | |
EP2575842A4 (en) | COMPOSITION COMPRISING THE EXTRACT OF PHYSALIS ALKEKENGI VAR. FRANCHETI HORT AS AN ACTIVE INGREDIENT FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASES | |
EP4302825A3 (en) | Pharmaceutical compositions for treatment of inappetence | |
GB2525517A (en) | Topical preparation for pain relief | |
WO2014102483A3 (fr) | Composition cosmetique ou dermatologique a base d'extraits d'iris et son utilisation | |
MX2022014763A (es) | Composiciones de grapiprant y metodos para usar las mismas. | |
MY160160A (en) | Anti-wart pharmaceutical composition and method for treating wart | |
WO2015063613A3 (en) | Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents | |
WO2014116015A3 (ko) | 자죽염을 포함하는 알츠하이머병 예방용 조성물 및 자죽염의 제조방법 | |
MX366309B (es) | Composicion farmaceutica para el tratamiento de inflamacion y dolor. | |
MX2014010926A (es) | Composicion herbaria para el tratamiento de transtornos metabolicos. | |
BR112014004737A2 (pt) | composto de composição de cloridrato de ambroxol e método de preparação do composto | |
WO2012108748A3 (ko) | 합환피 추출물을 포함하는 뇌암 치료용 조성물 및 화장료 조성물 | |
WO2013038200A3 (en) | Neurodevelopmental disorders | |
WO2012108747A3 (ko) | 토목향 추출물을 포함하는 뇌암 치료용 조성물 및 화장료 조성물 |